Pillstats
OTC · Spray, Metered · Nasal

Budesonide

Budesonide

5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
5 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)19831
US makers5 labelers
Packages8
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.410$0.819$1.23$1.64Dec 2025Apr 2026Jul 2026
$1.387
Latest avg · Jul 22, 2026
-3%
Since Dec 17, 2025
5
Active US suppliers
63%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.1K6.1K9.2K12K2025 Q12025 Q22025 Q32025 Q42026 Q1
8.1K
Rx · 2026 Q1
40K
Units dispensed
-24%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it5 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Apotex Corp.unknown3SUPPLYING
Rugby Laboratoriesunknown2SUPPLYING
EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)unknown1SUPPLYING
CVS Pharmacyunknown1SUPPLYING
WALGREEN COMPANYunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.